A Comprehensive Review of Guillain-Barré Syndrome (GBS)

[{“box”:0,”content”:”n[if 992 equals=”Open Access”]n

n

n

n

Open Access

nn

n

n[/if 992]n[if 2704 equals=”Yes”]n

n

Notice

nThis is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.n

n[/if 2704]n

n

Year : 2025 [if 2224 equals=””]25/09/2025 at 3:22 PM[/if 2224] | [if 1553 equals=””] Volume : 15 [else] Volume : 15[/if 1553] | [if 424 equals=”Regular Issue”]Issue : [/if 424][if 424 equals=”Special Issue”]Special Issue[/if 424] [if 424 equals=”Conference”][/if 424] 03 | Page : 1 5

n

n

nn

n

n

n

    By

    n

    [foreach 286]n

    n

    Tejal Kaushik, Ria Bangia, Sandeep Sirohi, Surya Prakash D. V,

    n t

  • n

    n[/foreach]

    n

n[if 2099 not_equal=”Yes”]n

    [foreach 286] [if 1175 not_equal=””]n t

  1. Student, Student, Assistant Professor, Assistant Professor, Department of Biotechnology, Meerut Institute of Engineering and Technology, Meerut, Department of Biotechnology, Meerut Institute of Engineering and Technology, Meerut, Department of Botany, Hariom Saraswati P. G. College, Haridwar, Department of Biotechnology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh, Uttar Pradesh, Uttrakhand, Uttar Pradesh, India, India, India, India

    2. n[/if 1175][/foreach]

n[/if 2099][if 2099 equals=”Yes”][/if 2099]n

n

Abstract

n

n

nThe rare but potentially life-threatening immune-mediated condition dubbed Guillain-Barré syndrome (GBS) impacts the peripheral nerves and nerve roots and is generally brought on by infections. As was the scenario during the Zika virus outbreaks in Latin America (2015) and French Polynesia (2013), the incidence of GBS may consequently escalate during influenza outbreaks. Considering GBS’s clinical features and ailments course are multiple and there are currently no global clinical guidelines, the identification and management of the disorder can be problematic. For the evaluation and therapy of GBS, we have developed a generic guideline to assist medical professionals particularly during an outbreak. The ten-step arrangement of the guideline makes it easier for practitioners in clinical practice and has its foundation on expert consensus and the most recent literature. We commence with an overview of the differential diagnoses, clinical versions, and diagnostic criteria for GBS. Identifying the clinical course and outcome, overseeing complications and adverse effects, tracking and addressing the disease progression, early identification and evaluation of GBS, admission to the critical care unit, as well as the indication and selection of treatment are all wrapped in the 10 segments.nn

n

n

n

Keywords: Guillain-Barré syndrome, peripheral nerves, nerve roots, GBS incidence, neuropathy

n[if 424 equals=”Regular Issue”][This article belongs to Research and Reviews : A Journal of Life Sciences ]

n

[/if 424][if 424 equals=”Special Issue”][This article belongs to Special Issue under section in Research and Reviews : A Journal of Life Sciences (rrjols)][/if 424][if 424 equals=”Conference”]This article belongs to Conference [/if 424]

n

n

n

How to cite this article:
nTejal Kaushik, Ria Bangia, Sandeep Sirohi, Surya Prakash D. V. [if 2584 equals=”][226 wpautop=0 striphtml=1][else]A Comprehensive Review of Guillain-Barré Syndrome (GBS)[/if 2584]. Research and Reviews : A Journal of Life Sciences. 29/07/2025; 15(03):1-5.

n

How to cite this URL:
nTejal Kaushik, Ria Bangia, Sandeep Sirohi, Surya Prakash D. V. [if 2584 equals=”][226 striphtml=1][else]A Comprehensive Review of Guillain-Barré Syndrome (GBS)[/if 2584]. Research and Reviews : A Journal of Life Sciences. 29/07/2025; 15(03):1-5. Available from: https://journals.stmjournals.com/rrjols/article=29/07/2025/view=0

nn

n

n[if 992 equals=”Open Access”]Full Text PDF[/if 992]n

n

n[if 992 not_equal=”Open Access”]n

n

n[/if 992]n

nn

nnn

n[if 379 not_equal=””]nn

Browse Figures

n

n

n[foreach 379]

figures

[/foreach]n

n

n

n[/if 379]

n

n

n

n

n

References n

n[if 1104 equals=””]n

  1. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: A systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–33.
  2. Guillain G. Sur un syndrome de radiculo-nevrite avec hyperalbuminose du liquide cephalo-rachidien sans reaction cellulaire. Remarques sur les caracters cliniques et graphiques des reflexes tendineux. Bull Mem Soc Med Hop Paris. 1916;40:1462–70.
  3. Webb AJ, Brain SA, Wood R, Rinaldi S, Turner MR. Seasonal variation in Guillain-Barré syndrome: A systematic review, meta-analysis and Oxfordshire cohort study. J Neurol Neurosurg Psychiatry. 2015;86(11):1196–201.
  4. Langmuir AD, Bregman DJ, Kurland LT, Nathanson N, Victor M. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol. 1984;119(6):841–79.
  5. Salmon DA, Proschan M, Forshee R, et al. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: A meta-analysis. Lancet. 2013;381(9876):1461–8.
  6. Hocker S, Nagarajan E, Rubin M, Wijdicks EFM. Clinical factors associated with Guillain-Barré syndrome following surgery. Neurol Clin Pract. 2018;8(3):201–6.
  7. Kusunoki S, Shiina M, Kanazawa I. Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: Evidence of molecular mimicry. Neurology. 2001;57(4):736–8.
  8. Geleijns K, Roos A, Houwing-Duistermaat JJ, et al. Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome. J Immunol. 2006;177(6):4211–7.
  9. Wakerley BR, Yuki N. Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes. Pract Neurol. 2015;15(2):90–9.
  10. Kmezic I, Samuelsson K, Finn A, et al. Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies. Eur J Neurol. 2022;29(9):2810–22.
  11. Lunn MP. Preventing expensive harms in Guillain-Barré syndrome. Lancet Neurol. 2021;20(4):249–51.
  12. Doets AY, Walgaard C, Lingsma HF, et al. International validation of the Erasmus Guillain-Barré Syndrome respiratory insufficiency score. Ann Neurol. 2022;91(4):521–31.
  13. Misawa S, Kuwabara S, Sato Y, et al. Safety and efficacy of eculizumab in Guillain-Barré syndrome: A multicentre, double-blind, randomised phase 2 trial. Lancet Neurol. 2018;17(6):519–29.
  14. Kim JK, Bae JS, Kim DS, et al. Prevalence of anti-ganglioside antibodies and their clinical correlates with Guillain-Barré syndrome in Korea: A nationwide multicenter study. J Clin Neurol. 2014;10(2):94–100.
  15. Koga M, Yuki N, Ariga T, Morimatsu M, Hirata K. Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome? J Neuroimmunol. 1998;86(1):74–9.
  16. Yamagishi Y, Kuwahara M, Suzuki H, et al. Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2020;91(12):1339–42.
  17. Luijten LWG, Doets AY, Arends S, et al. Modified Erasmus GBS respiratory insufficiency score: A simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2023;94(4):300–8.
  18. van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barré syndrome. Neurology. 2013;80(18):1650–4.

nn[/if 1104][if 1104 not_equal=””]n

    [foreach 1102]n t

  1. [if 1106 equals=””], [/if 1106][if 1106 not_equal=””],[/if 1106]

    2. n[/foreach]

n[/if 1104]

n

nn[if 1114 equals=”Yes”]n

n[/if 1114]

n

n

[if 424 not_equal=””]Regular Issue[else]Published[/if 424] Subscription Review Article

n

n

[if 2146 equals=”Yes”][/if 2146][if 2146 not_equal=”Yes”][/if 2146]n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n[if 1748 not_equal=””]

[else]

[/if 1748]n

n[if 1746 equals=”Retracted”]n

n

n

n

[/if 1746]n[if 4734 not_equal=””]

n

n

n

[/if 4734]n

n

Volume 15
[if 424 equals=”Regular Issue”]Issue[/if 424][if 424 equals=”Special Issue”]Special Issue[/if 424] [if 424 equals=”Conference”][/if 424] 03
Received 29/04/2025
Accepted 27/07/2025
Published 29/07/2025
Retracted
Publication Time 91 Days

n

n

100

nn

n

Login

n
My IP
n

PlumX Metrics

nn

n

n

n[if 1746 equals=”Retracted”]n

[/if 1746]nnn

nnn”}]